Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum The Cytek Aurora delivers on Cytek’s promise to make high-quality flow cytometry accessible to a larger number of researchers and clinicians. The Series C funding round will facilitate the expansion of Cytek’s footprint around the world. FREMONT, Calif. — Cytek Biosciences Inc., the preeminent provider of […]
OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery Cambridge–Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to […]
Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which […]
Integrating CNV analysis into a NextGen sequencing clinical analytics platform Bozeman, MT — Golden Helix, Inc., an industry-leading genomic analytics company that specializes in clinical Next-Gen Sequencing analysis software, has announced today that the National Institutes of Health awarded them a Phase 2 SBIR Grant 2R44 GM125432-02 “Integrating CNV analysis into a NextGen sequencing clinical analytics […]
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two […]
System integrates phenotypic and genomic information at massive scale to define heterogeneity in cell populations, accelerate research, drug discovery and drug development DURHAM, N.C.–Celldom, Inc. today announced that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health’s National Institute of General Medical Sciences […]
Former Chief Operations Officer and Delta™ System developer Ariel Notcovich promoted to drive industry adoption of the company’s core biomolecule characterization platform SOUTH SAN FRANCISCO, Calif. – Biodesy, Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G. Notcovich to Chief Executive Officer, and the completion of a $20 million Series C financing. […]
Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer reviewed Phase 1 SBIR grant from NIH NCATS titled: “Digital representation of chemical mixtures to aid drug discovery and formulation”. InChI provides a concise, canonical, and unique summary of a compound rather than a […]
ORLANDO, FLA – Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to increase capacity for its novel human-on-a-chip technology, and prepare its systems for regulatory approval utilizing advanced PKPD […]
Pullach, September 4th, 2018 – As part of its Horizon 2020 research and innovation program, the European Union has agreed to support the high-tech start-up FreshDetect GmbH headquartered in Pullach, Germany (Munich). The grant is intended to help the company expand its BFD-100, a portable device for rapid and precise quality control of food products, across […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
